Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunosuppressive Therapy Alone Versus Immunosuppressive Therapy Plus Oral Anticoagulation in the Treatment of Lower Extremity Venous Thrombosis Associated With Behcet's Disease

NCT06925698 is registered in ClinicalTrials.gov with Marmara University as lead sponsor.

NCT NCT06925698
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06925698 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunosuppressive Therapy Alone Versus Immunosuppressive Therapy Plus Oral Anticoagulation in the Treatment of Lower Extremity Venous Thrombosis Associated With Behcet's Disease
Lead sponsor
Marmara University
Phase
Phase 3
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
April 1, 2028
Enrollment
110 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

behcet disease, behcet disease and vascular involvement, deep venous thromboses, post thrombotic syndrome